Cd4 T-Lynphocyte count associated with patient infected with Typei &Typeii HIV attending Malali clinic and maternity, Kaduna Kaduna - Nigeria

Rabilu  Sani; Halima  Bello

doi:10.30574/gscbps.2021.17.1.0282

Authors

Rabilu Sani Department of Community Health Science, Shehu Idris Collage of Health Sciences and Technology, Makarfi, Kaduna State, Kaduna – Nigeria.
Halima Bello Department of Community Health Science, Shehu Idris Collage of Health Sciences and Technology, Makarfi, Kaduna State, Kaduna – Nigeria.

DOI:

https://doi.org/10.30574/gscbps.2021.17.1.0282

Keywords:

CD4 T- Lymphocyte, Type I & Type II HIV, Patient, Flow Cell, Dose Response

Abstract

Background: More than 25 million people in developing countries are living with HIV infection. An enormous global effort is now underway to bring antiretroviral treatment to at least 2.5 million of those infected. While drug prices have dropped considerably, the cost and technical complexity of laboratory tests essential for the management of HIV disease, such as CD4 cell counts, remain prohibitive. New, simple, and affordable methods for measuring CD4 cells that can be implemented in resource-scarce settings are urgently needed [5, 6].

Methods and Findings: Here we describe the development of a prototype for a simple, rapid, and affordable method for counting CD4 lymphocytes. Microliter volumes of blood without further sample preparation are stained with fluorescent antibodies, captured on a membrane within a minimized flow cell and imaged through microscope optics with the type of charge-coupled device developed for digital camera technology [10]. An associated computer algorithm converts the raw digital image into absolute CD4 counts and CD4 percentages in real time. The accuracy of this prototype system was validated through testing in the United States and Botswana, and showed close agreement with standard flow cytometry (r = 0.95) over a range of absolute CD4 counts, and the ability to discriminate clinically relevant CD4 count thresholds with high sensitivity and specificity [1,4]

Metrics

Metrics Loading ...

References

Joint United Nations Programme on HIV/AIDS, World Health Organization. AIDS epidemic update. 2004.

World Health Organization. World Health Organization. 3 by 5 progress report: December 2003 through June 2004.

Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2005 April 7.

O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A. Changes in plasma HIV-1 RNA and CD4 lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med. 2006; 334: 426 - 431.

Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ. Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 2007; 126: 946–954.

O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4 lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med. 2007; 126: 939–945.

Glencross DK, Stevens G, Scott LE, Mendelow BV, Stevens W. The challenge of laboratory monitoring of HIV. S Afr Med J. 2002; 92: 248.

Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4 T-cell enumeration. Cytometry. 2002; 50: 69–77.

Huff B. Low cost diagnostics. GMHC Treat Issues. 2001; 15: 1–4.

Bartholomew C. Prices of CD4 assays and viral load tests must be reduced for developing countries. BMJ. 2001; 323: 809–810.

Sherman GG, Galpin JS, Patel JM, Mendelow BV, Glencross DK. CD4 T cell enumeration in HIV infection with limited resources. J Immunol Methods. 1999; 222: 209–217.

Janossy G, Jani IV, Bradley NJ, Bikoue A, Pitfield T. Affordable CD4 -T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diagn Lab Immunol. 2002; 9: 1085–1094.

Kannangai R, Ramalingam S, Jesudason MV, Vijayakumar TS, Abraham OC. Correlation of CD4 T-Cell counts estimated by an immunocapture technique (Capcellia) with viral loads in human immunodeficiency virusseropositive individuals. Clin Diagn Lab Immunol. 2001; 8: 1286–1288.

Kannangai R, Prakash KJ, Ramalingam S, Abraham OC, Mathews KP. Peripheral CD4 /CD8 T-lymphocyte counts estimated by an immunocapture method in the normal healthy south Indian adults and HIV seropositive individuals. J Clin Virol. 2000; 17: 101–108.

Diagbouga S, Durand G, Sanou PT, Dahourou H, Ledru E. Evaluation of a quantitative determination of CD4 and CD8 molecules as an alternative to CD4 and CD8 T lymphocyte counts in Africans. Trop Med Int Health. 1999; 4: 79–84.

Landay A, Ho JL, Hom D, Russell T, Zwerner R. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS. 1993; 7: 1565–1568.

Didier JM, Katachkine MD, Demouchy C, Moat C, Diagbouga S. Comparative assessment of five alternative methods for CD4 T-lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr. 2001; 26: 193–195.

Lyamuya EF, Kagoma C, Mbena EC, Urassa WK, Pallangyo K. Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods. 1996; 195: 103–112.

Shapiro H. “Cellular astronomy”—A foreseeable future in cytometry. Cytometry A. 2004; 60: 115–124.

Janossy G, Jani IV, Kahan M, Barnett D, Mandy F. Precise CD4 T-cell counting using red diode laser excitation: For richer, for poorer. Cytometry B Clin Cytom. 2002; 50: 78–85.

Goodey AP, McDevitt JT. Multishell microspheres with integrated chromatographic and detection layers for use in array sensors. J Am Chem Soc. 2003; 125: 2870–2871.

Christodoulides N, Tran M, Floriano PN, Rodriguez M, Goodey A. A microchip-based multianalyte assay system for the assessment of cardiac risk. Anal Chem. 2002; 74: 3030–3036.

Goodey A, Lavigne JJ, Savoy SM, Rodriguez MD, Curey T. Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities. J Am Chem Soc. 2001; 123: 2559–2570.

Floriano PN, Christodoulides N, Romanovicz D, Bernard B, Simmons GW. Membrane-based on-line optical analysis system for rapid detection of bacteria and spores. Biosens Bioelectron. 2005; 20: 2079–2088.

Bland JM, Altman DG. Measuring agreement in methods comparison studies. Stat Methods Med Res. 1999; 8: 135–160.

Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. J Clin Chem Clin Biochem. 1983; 21: 709–720.

Whitby L, Granger V, Storie I, Goodfellow K, Sawle A. Quality control of CD4 T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993–2001) Cytometry. 2002; 15: 102–110.

Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S. Top ten biotechnologies for improving health in developing countries. Nat Genet. 2002; 32: 229–232.

Harris E. Developing essential scientific capability in countries with limited resources. Nat Med. 1996; 2: 737– 739.

Harris E, Tanner M. Health technology transfer. BMJ. 2000; 321: 817–820.